elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q24658529-34A02817-DFC9-4484-9965-7749102CE217
Q24658529-34A02817-DFC9-4484-9965-7749102CE217
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24658529-34A02817-DFC9-4484-9965-7749102CE217
Protocol of a randomised phase III clinical trial of sequential capecitabine or 5-fluorouracil plus bevacizumab (Cape/5-FU-Bmab) to capecitabine or 5-fluorouracil plus oxaliplatin plus bevacizumab (CapeOX/mFOLFOX6-Bmab) ..
P304
Q24658529-34A02817-DFC9-4484-9965-7749102CE217
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24658529-34A02817-DFC9-4484-9965-7749102CE217
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2fd4a5f9f6c836b96b5b6002d53938feb929837e
P304
e011454
http://www.w3.org/2001/XMLSchema#string